Core Insights - Bausch Health's treatment aimed at preventing brain dysfunction in liver cirrhosis patients failed to meet the primary endpoint in a late-stage clinical trial [1] Company Summary - Bausch Health announced that its late-stage trial for a treatment targeting brain dysfunction in patients with liver cirrhosis did not achieve its main goal [1]